김태곤 (Vanderbilt University Medical Center)님 | 한빛사연구자 > 한빛사

Vanderbilt University Medical Center

최종업데이트 2023.11.28.

- 김태곤(Vanderbilt University Medical Center)
VISTA-mediated immune evasion in cancer
- Exp. Mol. Med., 01 November 2024 | https://doi.org/10.1038/s12276-024-01336-6
- 2024-11
- 한빛사논문
- 김태곤(Vanderbilt University Medical Center)
PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
- J. Clin. Invest., Dec 07 2023, e164325 | https://doi.org/10.1172/JCI164325
- 2023-12
- 한빛사논문
LAIR-1 agonism as a therapy for acute myeloid leukemia
- J. Clin. Invest., Nov 15 2023, 133 (22) e169519 | https://doi.org/10.1172/JCI169519
- 2023-11
- 의약학
- 한빛사논문
- 김태곤(Yale University School of Medicine)
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
- Nat. Rev. Drug Discov., Published 14 June 2022 | https://doi.org/10.1038/s41573-022-00493-5
- 2022-06
- 한빛사논문
- 김태곤(Yale University School of Medicine)
Defining and Understanding Adaptive Resistance in Cancer Immunotherapy
- Trends Immunol., Published online: May 22, 2018 | DOI: https://doi.org/10.1016/j.it.2018.05.001
- 2018-05
- 한빛사논문

연구자 ID

저자논문